Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
University of Colorado Cancer Center · University of Colorado Denver · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
736
total citations
- FWCI
- 71.14
- Percentile
- 100%
- References
- 15
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Medicine
- Salvage therapy
- Internal medicine
- Rituximab
- Transplantation
- Oncology
- Hematopoietic stem cell transplantation
- Autologous stem-cell transplantation
No related works found for this paper.